Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Thai Authorities Warn Excessive Antibiotics Use Leads To 30,000 Deaths

This article was originally published in PharmAsia News

Executive Summary

Thai authorities warn that excessive use of antibiotics is leading to 30,000 deaths a year because of development of drug-resistant varieties of bacterial infections.

You may also be interested in...



LifeSignals Plans To Market Biosensor Patch To Help Consumer Identify COVID-19 Symptoms

LifeSignals plans to soon launch a biosensor patch to consumers to help them monitor for potential symptoms of COVID-19. 

No Hiding In Social Media: More False COVID-19 Treatment Claims Found By US Agencies

FDA and FTC's latest warning letters include the first firm marketing CBD products linked with bogus COVID-19 claims. Latest warnings also mark the first the agencies submitted based completely or nearly entirely on regulatory violations found in businesses social media postings.

Trump Uses Defense Production Act To Push Ventilator Materials To GE, Medtronic, ResMed, Hill-Rom, Royal Philips And Vyaire

The US president used his DPA powers on 2 April to make sure the six manufacturers of medical ventilators get the materials and components they need to make the much-needed devices as the COVID-19 pandemic scythes through the US.

Topics

UsernamePublicRestriction

Register

SC081351

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel